CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 43 filers reported holding CYCLERION THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,704 | -36.8% | 10,842 | -4.4% | 0.00% | – |
| Q4 2022 | $7,442 | -50.4% | 11,341 | -36.9% | 0.00% | – |
| Q3 2022 | $15,000 | +50.0% | 17,968 | -2.2% | 0.00% | – |
| Q2 2022 | $10,000 | -50.0% | 18,368 | +0.5% | 0.00% | – |
| Q1 2022 | $20,000 | -54.5% | 18,268 | -28.6% | 0.00% | – |
| Q4 2021 | $44,000 | -57.7% | 25,568 | -24.7% | 0.00% | – |
| Q3 2021 | $104,000 | +188.9% | 33,968 | +272.7% | 0.00% | – |
| Q2 2021 | $36,000 | +71.4% | 9,114 | +22.6% | 0.00% | – |
| Q1 2021 | $21,000 | +425.0% | 7,434 | +547.6% | 0.00% | – |
| Q4 2020 | $4,000 | +300.0% | 1,148 | +675.7% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 148 | -52.4% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 311 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
| Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
| MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
| Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
| Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
| COLONY GROUP LLC | 102,884 | $44 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 592,237 | $256,971 | 0.00% |
| STATE STREET CORP | 115,414 | $50,078 | 0.00% |